Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can literally save lives. Here are tips from the American Society of Anesthesiologists (ASA) on what to do in case of a suspected overdose.
(BPT) - Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can save lives, says the American Society of Anesthesiologists (ASA).
“The tragic increase in overdose deaths is an alarming and devastating issue that touches so many of us,” said ASA President Mary Dale Peterson, M.D., MSHCA, FACHE, FASA. “If you can identify an overdose or alcohol poisoning, you are more likely to react quickly, making the difference between life and death for a family member, friend or stranger.”
Physician anesthesiologists have a critical role in fighting against overdoses, starting with managing patients’ pain after surgery or chronic pain in responsible ways. During Physician Anesthesiologists Week, Jan. 26-Feb. 1, ASA is joining forces with U.S. Surgeon General VADM, Jerome Adams, M.D., M.P.H., to empower everyone to recognize the following signs of an overdose or alcohol poisoning:
Any one of these signs should prompt a call to 911 for emergency medical care. Never leave an unconscious person alone, as they may be at risk of dying, including by choking on his or her own vomit. If an opioid overdose is suspected, naloxone should be administered immediately, if available. Naloxone is administered by injection or nasal spray and access to it is expanding on a state-by-state basis. It can be prescribed by a physician and often is carried by police officers and emergency medical responders. Additionally, it’s increasingly available over the counter at some pharmacies.
“To stem the tide of the opioid overdose epidemic, we need everyone to consider themselves a first responder. We need to encourage everyone in our communities to carry naloxone and know how to use it,” said U.S. Surgeon General, VADM, Jerome M. Adams, M.D., M.P.H., a physician anesthesiologist who issued a Surgeon’s General’s advisory in 2018 calling for increased awareness and use of the medication. “When on hand, naloxone may mean the difference between life and death, and can be a first step to getting someone onto the pathway of recovery.”
Anyone who takes opioids to manage their pain may be at-risk for an overdose. In recent years, opioids were the go-to pain reliever for everything from backaches and injuries to post-surgical and chronic pain. In 2017, more than 190 million prescriptions were written for opioids. While they can be effective for short-term pain, chronic use can lead to abuse. Every day 130 people die from opioid overdoses, according to the Centers for Disease Control and Prevention.
“ASA strongly agrees with the Surgeon General and supports policies that promote access to naloxone and safe and effective pain management care,” said Dr. Peterson. “All of our members have a significant interest in reducing misuse, abuse and diversion of opioids that have led to unintended deaths.”
To learn more about the critical role physician anesthesiologists play before, during and after surgery, visit asahq.org/WhenSecondsCount. ASA also offers an opioid overdose resuscitation guide that provides guidance on symptoms of an overdose and how to help.
One in eight U.S. women will develop invasive breast cancer in their lifetime. The treatment of invasive breast cancer should be personalized because what is best for one woman may not be right for another. If you have breast cancer, it's important to take an active role in your health by learning about your available treatment options. An ongoing, collaborative discussion with your doctor is key in determining what treatment option best fits your individual needs.
(BPT) - As a commercial airline pilot with nearly 30 years of experience, Diane Sandoval, 50, is no stranger to making difficult decisions. However, she faced one of her toughest challenges not in the skies, but when she discovered a small lump in her left breast during a self-examination. Her worst fear was confirmed after a visit to her doctor when she was diagnosed with early-stage breast cancer.
Following an inconclusive mammogram and ultrasound, Sandoval learned she had several small tumors. She underwent a mastectomy to remove the tumors followed by breast reconstruction, putting her piloting career on pause.
The next big question was whether she should receive chemotherapy or not. Her physician recommended a genomic test — the Oncotype DX Breast Recurrence Score test. This tool has been proven to determine whether chemotherapy will be beneficial for individuals recently diagnosed with early-stage breast cancer. The test provides a personalized score based on the biology of the patient’s tumor that can help tailor treatment decisions for their individual cancer. Recent results from the largest breast cancer study ever conducted, called TAILORx, confirmed that the test clearly identified the 70 percent of women with early-stage breast cancer who receive no benefit from chemotherapy, as well as the remaining 30 percent of women for whom chemotherapy can be life-saving.
Sandoval is one of the nearly 1 million women who has put chemotherapy to the test with this genomic test. Her score confirmed that her risk of experiencing a breast cancer recurrence was low and she would not benefit from chemotherapy. As a result, she felt confident that she could forgo chemotherapy and its associated side effects. Subsequently, she was able to resume her career as a pilot and her active lifestyle.
She recently joined a campaign called “Put Chemo to the Test” to raise awareness of the Oncotype DX test and encourage women recently diagnosed with early-stage breast cancer to ask their doctor to order it before finalizing their treatment plan.
“I hope to help women with early-stage breast cancer better understand their treatment options by raising awareness of this test and how it can determine whether they are part of the majority of patients who may be spared chemotherapy and its well-known side effects or are among the important minority of patients who could receive life-saving benefit from chemotherapy,” said Sandoval.
One in eight U.S. women will develop invasive breast cancer in their lifetime. The treatment of invasive breast cancer should be personalized because what is best for one woman may not be right for another. If you have breast cancer, it's important to take an active role in your health by learning about your available treatment options. An ongoing, collaborative discussion with your doctor is key in determining what treatment option best fits your individual needs. Below are a few questions to ask your doctor:
Breast cancer patients and caregivers can visit ChemoYesorNo.org to download the full physician discussion guide and learn more about the test.
“I want women who were recently diagnosed with early-stage breast cancer to know that there is no one-size-fits-all treatment approach,” said Sandoval. “The test gave me the confidence I needed to forgo chemotherapy, which has allowed me to continue to enjoy my life with my husband. Ask your doctor to order this genomic test before finalizing your treatment plan.”
(BPT) - Most patients undergoing knee surgery want to know when they’ll be able to return to a pain-free, active lifestyle and do the things they once enjoyed before knee pain took over. For 58-year-old Kathleen Cohan, this meant a desire to return to mountain biking, hiking and skiing — activities she had always loved to do as a youth and continued to enjoy with her husband in their hometown of Golden, Colorado.
Cohan recently participated in a clinical trial to treat persistent knee pain caused by a meniscus tear. After receiving the NUsurface Meniscus Implant — the first “artificial meniscus” — she completed a six-week rehabilitation program and was ready to return to doing the things she loved.
“The NUsurface Meniscus Implant changed my life. It feels great to not have to worry before I choose an activity about how much pain I’ll be in afterward,” Cohan says. “My husband and I recently went on a 100-mile mountain bike trip, and I climbed a 14,000-foot peak last month and my knee didn’t bother me at all. The implant gave me a chance to extend my activity level as long as I possibly can.”
Three months after surgery, most patients have completely recovered and are able to return to many activities that were too painful or difficult previously. Once you’ve been cleared by your doctor, the safest way to restart activity after meniscus surgery is to find activities that avoid placing unnecessary stress on your knee joint. Here are three activities to help you move safely after knee surgery:
1. Walk (don’t run!). Experts say walking outside your home three to five times each day is one of the best ways to regain your knee strength. While you may need to adjust the length of your step and speed, you will be able to spend more time walking for exercise once your muscle strength improves.
2. Dance. While you should avoid high-impact moves like jumping or lifts, ballroom dancing and gentle modern dancing are great ways to use leg muscles, engage in aerobic activity and have fun! Just be sure to avoid abrupt movements or twists that could potentially put your knee out of alignment.
3. Swim. Once the wound has healed, many people choose swimming as their exercise of choice as it’s not a weight-bearing activity and therefore reduces stress to the joints. If your knee is still a bit tender, opt for water aerobics or pool walking.
Want to mix it up? You can feel safe doing many other recommended activities such as yoga, golf, boating, aerobics or rowing. If you have experience prior to your surgery doing more intense activities, like Cohan, your doctor may give you the go-ahead to resume cycling, hiking, cross-country skiing and doubles tennis. Whichever activity you choose, remember that rushing into activities before you’ve recovered sufficiently may put you at risk for complications, so be sure to check with your doctor first before resuming any activity after meniscus surgery.
To be eligible for the NUsurface Meniscus Implant clinical studies, you must be between the ages of 30 and 75, and have pain after medial (the inside of the knee) meniscus surgery at least six months ago. To find a study site near you, visit www.activeimplants.com/kneepaintrial.
Interested in Publishing on The Health IDEA?
Send your query to the Publisher today!